Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-12 11:13 am Sale |
2022-09-09 | 13G | ChemoCentryx, Inc. CCXI |
FMR CORP | 7,734 0.010% |
-10,496,985 (-99.93%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | ChemoCentryx, Inc. CCXI |
Schall Thomas J. | 4,525,787 6.500% |
188,375 (+4.34%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | ChemoCentryx, Inc. CCXI |
RA Capital Management, L.P. | 0 0.000% |
-4,776,548 (Position Closed) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | ChemoCentryx, Inc. CCXI |
The Vanguard Group | 5,098,980 7.280% |
351,510 (+7.40%) |
Filing History |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | ChemoCentryx, Inc. CCXI |
FMR CORP | 10,504,719 14.999% |
123,457 (+1.19%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | ChemoCentryx, Inc. CCXI |
BLACKROCK INC BLK |
4,326,487 6.200% |
-478,210 (-9.95%) |
Filing History |
| 2021-10-13 6:54 pm Sale |
2021-10-12 | 13D | ChemoCentryx, Inc. CCXI |
Vifor (International) Ltd. | 5,194,085 7.400% |
-4,089,660 (-44.05%) |
Filing History |
| 2021-06-09 07:52 am Sale |
2021-05-31 | 13G | ChemoCentryx, Inc. CCXI |
WELLINGTON MANAGEMENT CO LLP | 482,747 0.690% |
-5,665,932 (-92.15%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
RA Capital Management, L.P. | 4,776,548 6.900% |
1,577,159 (+49.30%) |
Filing History |
| 2021-02-16 3:01 pm Sale |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
Cormorant Asset Management LP | 1,200,000 1.700% |
-2,186,208 (-64.56%) |
Filing History |
| 2021-02-16 1:50 pm Sale |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
Schall Thomas J. | 4,337,412 6.300% |
-347,363 (-7.41%) |
Filing History |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
The Vanguard Group | 4,747,470 6.860% |
4,747,470 (New Position) |
Filing History |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | ChemoCentryx, Inc. CCXI |
FMR CORP | 10,381,262 14.999% |
1,640,977 (+18.77%) |
Filing History |
| 2021-02-03 2:14 pm Sale |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
WELLINGTON MANAGEMENT CO LLP | 6,148,679 8.880% |
-865,467 (-12.34%) |
Filing History |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
BLACKROCK INC BLK |
4,804,697 6.900% |
691,541 (+16.81%) |
Filing History |
| 2020-11-10 09:02 am Purchase |
2020-10-30 | 13G | ChemoCentryx, Inc. CCXI |
WELLINGTON MANAGEMENT CO LLP | 7,014,146 10.180% |
7,014,146 (New Position) |
Filing History |
| 2020-07-31 4:54 pm Sale |
2020-07-30 | 13D | ChemoCentryx, Inc. CCXI |
Vifor (International) Ltd. | 9,283,745 13.700% |
-693,378 (-6.95%) |
Filing History |
| 2020-07-16 07:56 am Sale |
2020-07-14 | 13D | ChemoCentryx, Inc. CCXI |
Vifor (International) Ltd. | 9,977,123 14.700% |
-699,702 (-6.55%) |
Filing History |